- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory Cells in Diffuse Large B Cell Lymphoma
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 8, Pages 2418
Publisher
MDPI AG
Online
2020-07-30
DOI
10.3390/jcm9082418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche
- (2020) Aparna Shinde et al. Oncogenesis
- The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
- (2020) Paulina Stefaniuk et al. Cancer Management and Research
- The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites
- (2020) Sarah Libring et al. Cancers
- Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer
- (2019) Aparna Shinde et al. CANCER RESEARCH
- PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T cell-inflamed phenotype
- (2019) James Godfrey et al. BLOOD
- The IL ‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma
- (2019) Hind Hashwah et al. EMBO Molecular Medicine
- Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma
- (2019) Yaqing Cao et al. Frontiers in Oncology
- Targeting B-Cell Maturation Antigen (BCMA) with CC-93269, a 2+1 T Cell Engager, Elicits Significant Apoptosis in Diffuse Large B-Cell Lymphoma Preclinical Models
- (2019) Patrick R. Hagner et al. BLOOD
- STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas
- (2019) Roberto Tamma et al. LEUKEMIA & LYMPHOMA
- Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
- (2018) Frank Vari et al. BLOOD
- Modulation the expression of natural killer cell activating receptor (NKp44) in the peripheral blood of diffuse large B-cell lymphoma patients and the correlation with clinic pathological features
- (2018) Enas Said Essa et al. CLINICAL IMMUNOLOGY
- Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
- (2018) Thomas A. Ollila et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells
- (2018) Kevin M. Friedman et al. HUMAN GENE THERAPY
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
- (2018) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Autocrine Fibronectin Inhibits Breast Cancer Metastasis
- (2018) Aparna Shinde et al. MOLECULAR CANCER RESEARCH
- Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma
- (2018) Roberto Tamma et al. Oncotarget
- Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis
- (2018) Shidai Mu et al. Cancer Cell International
- Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
- (2018) Elena J. Orlando et al. NATURE MEDICINE
- Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
- (2018) Shih-Feng Cho et al. Frontiers in Immunology
- Neutrophil extracellular traps induced by IL-8 promote diffuse large B cell lymphoma progression via the TLR9 signaling
- (2018) Man Nie et al. CLINICAL CANCER RESEARCH
- Profiling Immune Escape in Hodgkin’s and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining
- (2018) Sarah Péricart et al. Cancers
- Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
- (2017) Robert Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy
- (2017) Shana D. Hardy et al. Oncotarget
- Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy
- (2017) Seul Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- The Immune Microenvironment: A Major Player in Human Cancers
- (2017) W.H. Fridman et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
- (2016) R. Gardner et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
- (2016) Xiaojun Liu et al. CANCER RESEARCH
- CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL
- (2016) Benoit Manfroi et al. CANCER RESEARCH
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma
- (2016) Long Shen et al. Scientific Reports
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- T cells, mast cells and microvascular density in diffuse large B cell lymphoma
- (2015) Christian Marinaccio et al. CLINICAL AND EXPERIMENTAL MEDICINE
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
- (2015) D Sommermeyer et al. LEUKEMIA
- The biology of innate lymphoid cells
- (2015) David Artis et al. NATURE
- The tumor microenvironment shapes hallmarks of mature B-cell malignancies
- (2015) K H Shain et al. ONCOGENE
- Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs
- (2015) G. Gasteiger et al. SCIENCE
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Large B-Cell Lymphoma Rich in PD-1+ T Cells
- (2014) Sylvia Hartmann et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A new frontier in haematology - combining pharmacokinetic with pharmacodynamic factors to improve choice and dose of drug
- (2014) David Rey Arpon et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The role of molecular biology in the diagnosis of lymphoid neoplasms
- (2014) Marco Pizzi Frontiers in Bioscience-Landmark
- High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma
- (2014) Francesco Marchesi et al. HEMATOLOGICAL ONCOLOGY
- An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
- (2014) Soo Jeong Nam et al. LEUKEMIA & LYMPHOMA
- Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma
- (2014) Matthew J. Ahearne et al. VIRCHOWS ARCHIV
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- T-cell subsets in the germinal center
- (2013) Roybel R. Ramiscal et al. IMMUNOLOGICAL REVIEWS
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Lymphoma classification and the tools of our trade: an introduction to the 2012 USCAP Long Course
- (2013) Steven H Swerdlow MODERN PATHOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- On the cytokines produced by human neutrophils in tumors
- (2013) Cristina Tecchio et al. SEMINARS IN CANCER BIOLOGY
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Natural Killer Cells Modulation in Hematological Malignancies
- (2013) Céline Baier et al. Frontiers in Immunology
- CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
- (2012) B. G. Till et al. BLOOD
- Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation
- (2012) M. Gupta et al. BLOOD
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Hodgkin’s lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses
- (2012) Carolin Winkler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-associated neutrophils: friend or foe?
- (2012) Z. G. Fridlender et al. CARCINOGENESIS
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- Establishment, Characterization, and Successful Adaptive Therapy against Human Tumors of NKG Cell, a New Human NK Cell Line
- (2011) Min Cheng et al. CELL TRANSPLANTATION
- High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma
- (2011) Qi-chun Cai et al. MEDICAL ONCOLOGY
- Molecular pathogenesis of diffuse large B-cell lymphoma
- (2011) Christof Schneider et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Classifications of lymphoma; reflections of time and technology
- (2011) Clive R. Taylor et al. VIRCHOWS ARCHIV
- Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
- (2010) R. Zappasodi et al. CANCER RESEARCH
- Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors
- (2010) V. Marin et al. HAEMATOLOGICA
- Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
- (2010) Yi-Wei Li et al. JOURNAL OF HEPATOLOGY
- Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model
- (2010) Nicola Zizzo et al. LEUKEMIA & LYMPHOMA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Immunotherapy of cancer
- (2009) Hossein Borghaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
- (2008) M. Di Nicola et al. BLOOD
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of CD68 tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
- (2008) Sverker Hasselblom et al. PATHOLOGY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now